Naltrexone Hydrochloride NDC 23155-886

NDC codes

FDA NDC Directory

Product NDC (as listed)23155-886Labeler and product segments. Claims need a package NDC.

Product NDC at billing width23155-0886Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
23155-886-01	23155088601	100 TABLET, FILM COATED in 1 BOTTLE (23155-886-01)Marketed from Oct 6, 2023
23155-886-03	23155088603	30 TABLET, FILM COATED in 1 BOTTLE (23155-886-03)Marketed from Oct 6, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naltrexone Hydrochloride
Generic name (nonproprietary): naltrexone hydrochloride
Active ingredients: Naltrexone hydrochloride — 50 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207905
Marketing start: Oct 6, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Opioid Antagonists (Mechanism)
Identifiers: Product ID 23155-886_6ffda82d-69f6-40f7-90fd-53b628440934SPL ID 6ffda82d-69f6-40f7-90fd-53b628440934SPL set ID c67a22bb-d2bd-4da5-9d3e-6b5281f10891RxCUI 1483744UNII Z6375YW9SFUPC 0323155886030, 0323155886016
Pharmacologic class: Opioid Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N423155088601 followed by a unit qualifier and the quantity

Package 23155-0886-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 30, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Naltrexone Hydrochloride Tablets, USP are indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids. Naltrexone Hydrochloride Tablets, USP have not been shown to provide any therapeutic benefit except as part of an appropriate plan of management for the addictions.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207905

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207905
Product	Strength	Form · route	Labeler	Product NDC
Naltrexone Hydrochloride	Naltrexone hydrochloride 50 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-242